A Drug-drug Interaction Trial of Rifampicin Pharmacokinetics Effect on Fluzoparib

Clinical trial NCT04011124 · COMPLETED

Trial details

NCT number: NCT04011124
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male Subjects

Start date: 2019-07-24
Primary completion: 2019-09-16
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.